benign prostatic hyperplasia (bph) drugs market

Global Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-02-28
  • Report ID: 64923
  • Pages: 101
  • Format: prudent report format

Snapshot

The global Benign Prostatic Hyperplasia (BPH) Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Benign Prostatic Hyperplasia (BPH) Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Alpha-blocker
Phosphodiesterase Type-5 Inhibitors
5-alpha-Reductase Inhibitors

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Bayer HealthCare
Bristol-Myers Squibb
Valeant Pharmaceuticals
Endo Pharmaceuticals
Foresee Pharmaceuticals
Madrigal Pharmaceuticals
Merck
Novartis
Spectrum Pharmaceuticals
Takeda Pharmaceuticals
Teva
Advaxis
ANI Pharmaceuticals
BHR Pharma

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry
Figure Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Benign Prostatic Hyperplasia (BPH) Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Benign Prostatic Hyperplasia (BPH) Drugs
1.2.2 Downstream
Table Application Segment of Benign Prostatic Hyperplasia (BPH) Drugs
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Benign Prostatic Hyperplasia (BPH) Drugs Market by Type
3.1 By Type
3.1.1 Alpha-blocker
Table Major Company List of Alpha-blocker
3.1.2 Phosphodiesterase Type-5 Inhibitors
Table Major Company List of Phosphodiesterase Type-5 Inhibitors
3.1.3 5-alpha-Reductase Inhibitors
Table Major Company List of 5-alpha-Reductase Inhibitors
3.2 Market Size
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2020, by Type, in USD Million
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2020, by Type, in Volume
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Astellas Pharma (Company Profile, Sales Data etc.)
4.1.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.1.2 Astellas Pharma Products & Services
4.1.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Eli Lilly (Company Profile, Sales Data etc.)
4.2.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.2.2 Eli Lilly Products & Services
4.2.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.3.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.3.2 GlaxoSmithKline Products & Services
4.3.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi (Company Profile, Sales Data etc.)
4.4.1 Sanofi Profile
Table Sanofi Overview List
4.4.2 Sanofi Products & Services
4.4.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 ADC Therapeutics (Company Profile, Sales Data etc.)
4.5.1 ADC Therapeutics Profile
Table ADC Therapeutics Overview List
4.5.2 ADC Therapeutics Products & Services
4.5.3 ADC Therapeutics Business Operation Conditions
Table Business Operation of ADC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Bayer HealthCare (Company Profile, Sales Data etc.)
4.6.1 Bayer HealthCare Profile
Table Bayer HealthCare Overview List
4.6.2 Bayer HealthCare Products & Services
4.6.3 Bayer HealthCare Business Operation Conditions
Table Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.7.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.7.2 Bristol-Myers Squibb Products & Services
4.7.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Valeant Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
4.8.2 Valeant Pharmaceuticals Products & Services
4.8.3 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Endo Pharmaceuticals (Company Profile, Sales Data etc.)
4.9.1 Endo Pharmaceuticals Profile
Table Endo Pharmaceuticals Overview List
4.9.2 Endo Pharmaceuticals Products & Services
4.9.3 Endo Pharmaceuticals Business Operation Conditions
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Foresee Pharmaceuticals (Company Profile, Sales Data etc.)
4.10.1 Foresee Pharmaceuticals Profile
Table Foresee Pharmaceuticals Overview List
4.10.2 Foresee Pharmaceuticals Products & Services
4.10.3 Foresee Pharmaceuticals Business Operation Conditions
Table Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Madrigal Pharmaceuticals (Company Profile, Sales Data etc.)
4.11.1 Madrigal Pharmaceuticals Profile
Table Madrigal Pharmaceuticals Overview List
4.11.2 Madrigal Pharmaceuticals Products & Services
4.11.3 Madrigal Pharmaceuticals Business Operation Conditions
Table Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Merck (Company Profile, Sales Data etc.)
4.12.1 Merck Profile
Table Merck Overview List
4.12.2 Merck Products & Services
4.12.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
4.13 Novartis (Company Profile, Sales Data etc.)
4.13.1 Novartis Profile
Table Novartis Overview List
4.13.2 Novartis Products & Services
4.13.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)
4.14.1 Spectrum Pharmaceuticals Profile
Table Spectrum Pharmaceuticals Overview List
4.14.2 Spectrum Pharmaceuticals Products & Services
4.14.3 Spectrum Pharmaceuticals Business Operation Conditions
Table Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.15 Takeda Pharmaceuticals (Company Profile, Sales Data etc.)
4.15.1 Takeda Pharmaceuticals Profile
Table Takeda Pharmaceuticals Overview List
4.15.2 Takeda Pharmaceuticals Products & Services
4.15.3 Takeda Pharmaceuticals Business Operation Conditions
Table Business Operation of Takeda Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.16 Teva (Company Profile, Sales Data etc.)
4.16.1 Teva Profile
Table Teva Overview List
4.16.2 Teva Products & Services
4.16.3 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Cost, Gross Margin)
4.17 Advaxis (Company Profile, Sales Data etc.)
4.17.1 Advaxis Profile
Table Advaxis Overview List
4.17.2 Advaxis Products & Services
4.17.3 Advaxis Business Operation Conditions
Table Business Operation of Advaxis (Sales Revenue, Cost, Gross Margin)
4.18 ANI Pharmaceuticals (Company Profile, Sales Data etc.)
4.18.1 ANI Pharmaceuticals Profile
Table ANI Pharmaceuticals Overview List
4.18.2 ANI Pharmaceuticals Products & Services
4.18.3 ANI Pharmaceuticals Business Operation Conditions
Table Business Operation of ANI Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.19 BHR Pharma (Company Profile, Sales Data etc.)
4.19.1 BHR Pharma Profile
Table BHR Pharma Overview List
4.19.2 BHR Pharma Products & Services
4.19.3 BHR Pharma Business Operation Conditions
Table Business Operation of BHR Pharma (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration, in 2020
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs MMarket Concentration, in 2020
Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration, in 2020
Figure Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Hospitals, 2016-2020, in USD Million
Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Hospitals, 2016-2020, in Volume
6.1.2 Demand in Clinics
Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Clinics, 2016-2020, in USD Million
Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Clinics, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Others, 2016-2020, in USD Million
Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Benign Prostatic Hyperplasia (BPH) Drugs Market Share in 2026, by Application, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2021-2026, by Application, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Benign Prostatic Hyperplasia (BPH) Drugs Production 2016-2020, by Region, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2020, by Region, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2020, by Region, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.